Imaging malignant and apparent malignant transformation of benign gynaecological disease

A Y Lee, Liina Pōder, L Poder, A Qayyum, Aliya Qayyum, Z J Wang, B M Yeh, Benjamin M. Yeh, F V Coakley, Fergus V. Coakley
Clinical radiology · 2010 · vol. 65(12) , pp. 1031–1037 · doi:10.1016/j.crad.2010.07.006 · PMID:21070909 · W2082815843
review OA: closed CC0 ⤵ 3 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-06 ⓘ

This paper examines imaging techniques to distinguish malignant transformation from benign conditions in gynecological diseases.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715

MeSH descriptors

Adenomyoma Cell Transformation, Neoplastic Endometriosis Ovarian Neoplasms Teratoma Adenomyoma Adult Edema Edema Endometriosis Female Humans Magnetic Resonance Imaging Middle Aged Ovarian Diseases Ovarian Diseases Ovarian Neoplasms Teratoma Tomography, X-Ray Computed

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (37)

Cited by (3)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:16:54.825375+00:00
unpaywall
last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0 · commercial use OK